Commission Implementing Decision (EU) 2021/545 of 26 March 2021 authorising laboratories in Brazil, Cambodia, China, Mexico, South Africa, Tunisia, Ukraine and the United Kingdom to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.I Veterinary Issues
Joint committee decision (JCD)
279/2021
In force in the EEA
Yes
Legal Documents
Commission Implementing Decision (EU) 2021/545 of 26 March 2021 authorising laboratories in Brazil, Cambodia, China, Mexico, South Africa, Tunisia, Ukraine and the United Kingdom to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets
Durchführungsbeschluss (EU) 2021/545 der Kommission vom 26. März 2021 über die Zulassung von Laboratorien in Brasilien, China, Kambodscha, Mexiko, Südafrika, Tunesien, Ukraine und dem Vereinigten Königreich für die Durchführung serologischer Tests zur Kontrolle der Wirksamkeit von Tollwutimpfstoffen bei Hunden, Katzen und Frettchen
Kommisjonens gjennomføringsbeslutning (EU) 2021/545 av 26. mars 2021 om godkjenning av visse laboratorier i Brasil, Kambodsja, Kina, Mexico, Sør-Afrika, Tunisia, Ukraina og Det forente kongerike til å utføre serologiske tester for å kontrollere effektiviteten av rabiesvaksiner hos hunder, katter og ildrer
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.